The Commercializing Industrial Biotechnology (CIB) conference spotlights best practices, lessons learned, and technology innovations for accelerating commercial production of bio-based products and building the circular bioeconomy. This is the premier conference focused on scale-up and commercialization of new products in the synthetic biology, fermentation, and industrial biotechnology spaces.
You’ll engage with industrial biotech leaders and practitioners as you explore the latest in the field — including developments that are driving a new wave of products. At CIB, you'll hear hard-won lessons from industry veterans — and draw inspiration for your own technology development efforts while learning and networking about new enabling technologies, products, market needs, and companies.
This is the industrial biotechnology key players who's who conference. Come to share and learn how to bring the innovations from the lab to commercially viable, economic competitive and sustainable technology and product offerings that make material impact to our everyday life.![]()
Submit Your Abstract Now!
Get your submission in as soon as possible for review by the organizing committee, to be included in the technical program.
Submit an oral presentation for any of our conference topics, or a poster presentation to be featured during the poster session and reception.
The deadline for oral presentations is April 28th, 2026
Top Reasons to Attend CIB
- Hear hard-won lessons from industry veterans — and draw inspiration for your own technology development efforts
- Learn about new enabling technologies, products, market needs, and companies
- Network with technology leaders, and find new funders, collaborators, or teammates
- Gain visibility for your company and technology
- Share with a diverse audience and contribute to the future of biotechnology commercialization
